Breast Cancer Research and Treatment

, Volume 111, Issue 3, pp 569–570

ERCC1 expression in triple negative breast carcinoma: the paradox revisited

  • Angelo Sidoni
  • Fabio Cartaginese
  • Mariantonietta Colozza
  • Stefania Gori
  • Lucio Crinó
Letter to the editor

References

  1. 1.
    Rakha EA, El-Sayed ME, Green AR et al (2007) Prognostic markers in triple-negative breast cancer. Cancer 109:25–32PubMedCrossRefGoogle Scholar
  2. 2.
    Bauer KR, Brown M, Cress RD et al (2007) Descriptive analysis of estrogen receptor (ER)-negative, progesterone receptor (PR)-negative, and HER2-negative invasive breast cancer, the so-called triple-negative phenotype: a population-based study from the California cancer Registry. Cancer 109:1721–1728PubMedCrossRefGoogle Scholar
  3. 3.
    Dent R, Trudeau M, Pritchard KI et al (2007) Triple-negative breast cancer: clinical features and patterns of recurrence. Clin Cancer Res 13:4429–4434PubMedCrossRefGoogle Scholar
  4. 4.
    Tischkowitz M, Brunét JS, Bégin LR et al (2007) Use of immunohistochemical markers can refine prognosis in triple negative breast cancer. BMC Cancer 7:134–144PubMedCrossRefGoogle Scholar
  5. 5.
    Cleator S, Heller W, Coorbes (2007) Triple-negative breast cancer: therapeutic options. Lancet Oncol 8:235–244PubMedCrossRefGoogle Scholar
  6. 6.
    Carey La, Dees EC, Sawyer L et al (2007) The triple negative paradox: primary tumor chemosensivity of breast cancer subtypes. Clin Cancer Res 13:2329–2334PubMedCrossRefGoogle Scholar
  7. 7.
    Tan DSP, Marchiò C, Jones RL et al (2007) Triple negative breast cancer: molecular profiling and prognostic impact in adjuvant anthracycline-treated patients. Breast Cancer Res Treat. doi:10.1007/s10549-007-9756-8
  8. 8.
    Olaussen KA, Dunant A, Fouret P et al (2006) DNA repair by ERCC1 in non-small-cell lung cancer and cisplatin-based adjuvant chemotherapy. N Engl J Med 355:983–991PubMedCrossRefGoogle Scholar
  9. 9.
    Al-Haddad S, Zhang Z, Leygue E et al (1999) Psoriasin (S100A7) expression and invasive breast cancer. Am J Pathol 155:2057–2066PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC. 2007

Authors and Affiliations

  • Angelo Sidoni
    • 1
  • Fabio Cartaginese
    • 1
  • Mariantonietta Colozza
    • 2
  • Stefania Gori
    • 2
  • Lucio Crinó
    • 2
  1. 1.Institute of Pathologic Anatomy and Histology, Division of Cancer Research University of PerugiaPerugiaItaly
  2. 2.Medical Oncology DivisionAzienda OspedalieraPerugiaItaly

Personalised recommendations